Skip to main content

Table 2 Comparison of patients with and without primary care follow-up

From: Access to primary care is associated with better autoimmune hepatitis outcomes in an urban county hospital

 

Full cohort

Without PCa

With PCa

p

 

N (%)

N (%)

N (%)

 

n

83

57

26

 

Treated

67 (81)

41 (72)

26 (100)

0.002

Not treated due to decompensation/Childs B or C disease

6

6

0

 

Not treated because "No indication" according to clinician

2

2

0

 

Not treated because LFTs or liver enzymes either were normal, insignificantly elevated, or resolved on own

5

5

0

 

Unclear why not treated

2

2

0

 

Patient to follow up with PC physician

1

1

0

 

Remission

43 (52)

28 (49)

15 (58)

0.469

Noncompliance

10 (12)

6 (11)

4 (15)

1.000

Steroid median dose

40 (IQR 40–60)

40 (IQR 40–60)

40 (IQR 40–55)

0.535

Median time corticosteroids (months)

12 (14.5)

12 (IQR 5–23)

15 (IQR 12–28)

0.115

Median time to ALT normalization (months)

1.4 (IQR 0.8-3.3)

1.3 (IQR 0.8-3.7)

1.6 (IQR 0.6-2.9)

0.504

Relapses

23 (27)

12 (21)

11 (42)

0.380

  1. aPC = Primary Care (Defined as 6 months or greater of Internal Medicine and Family Medicine visit physician follow-up)